Akso Health Group
AHG · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | -$0 | -$0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 512.1% | -81.7% | 119.7% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -1.9% | 5.1% | 9.6% | 10.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -12% | -357.8% | -108.2% | -53.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -913.4% | -391.8% | -10.3% | -280.8% |
| EPS Diluted | -0.48 | -0.39 | -0.06 | -2.55 |
| % Growth | -23.1% | -550% | 97.6% | – |
| Operating Cash Flow | $0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | $0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | -$0 |